NYLI CBRE Global Infrastructure Megatrends Term Fund Common Shares (MEGI)
FairStock Score: 45/100 — MIXED
Key Financials
| Current Price | $14.19 |
| Market Cap | $792M |
| P/E Ratio | 4.58 |
| ROE | —% |
| Dividend Yield | 10.57% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look at MEGI as a specialized infrastructure fund, not an operating business with a durable moat. The NYLI CBRE name may give it some access and credibility, but from the figures provided I cannot identify pricing power, low-cost advantage, or switching costs. Financial health is the biggest worry: the FairStock Piotroski F-Score is 2/9, and its Altman Z-Score is 1.80, both pointing to weak quality and possible balance-sheet stress. The FairStock Score is only 45/100. Valuation looks superficially compelling. At the 2026-10-13 close of $13.99, the FairStock P/E is 4.51, and its Graham Number is $34.25, giving a 59.15% margin of safety. The dividend yield is 10.72%. But I have no filed revenue, net income, ROE, ROCE, debt-to-equity, or growth figures to verify that those earnings are recurring. A very low P/E can mean the market expects earnings to fall or that the payout is partly a return of capital. The lack of a Lynch category because there are only 0 years of filed results means I cannot judge consistency across a cycle. The 52-week range of $13.24-$15.89 shows the shares are near the low end. Graham would demand a margin of safety, but also verifiable earnings and assets. Here the quantitative margin is large, yet the quality signals and missing history mean the apparent cheapness may be fragile. I would need filed statements and distribution coverage before treating this as a true value opportunity.
In plain English: This fund owns a portfolio focused on global infrastructure trends and pays a high income stream. The price looks low compared with its estimated earning power and calculated asset value, but the financial-strength signals are weak and there is almost no filed history to judge consistency. Overall, it looks cheap on some measures but not clearly strong; the high payout and weak health scores make it a mixed picture.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer